The Patent Finder
AP

Alnylam Pharmaceuticals, Inc.

First filing 2002
OverviewNotableFeesChangesFamiliesPatent listSources & methods

308 patents currently held

51 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
167 more records may belong here and await a decision; they are not counted.

The next term ends in Nov 2026. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
68
Ending by 2030
Nov 2026
Next term end
148
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 19, 2026
    The maintenance fee for Process for Triphosphate Oligonucleotide Synthesis (US 9,035,041) comes due Nov 19, 2026. Unpaid by May 19, 2027, it lapses early.
  • 5 fees due Dec 20 to 30, 2026 · next Dec 20
  • 2 fees due Jan 2 to 28, 2027 · next Jan 2
  • 6 fees due Feb 6 to 20, 2027 · next Feb 6
  • 4 fees due Mar 3 to 15, 2027 · next Mar 3
  • 7 fees due May 3 to 28, 2027 · next May 3
  • 10 fees due Jun 1 to 24, 2027 · next Jun 1
  • 8 fees due Jul 2 to 30, 2027 · next Jul 2
  • 8 fees due Aug 2 to 25, 2027 · next Aug 2
  • 3 fees due Sep 12 to 24, 2027 · next Sep 12
  • 7 fees due Oct 2 to 26, 2027 · next Oct 2
  • 1 fee due Nov 5, 2027
    The maintenance fee for HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF (US 10,640,770) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

What they patent

The 5 largest of its 148 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 8,658,782Compositions And Methods For Inhibiting Expression Of Factor V
In force
 · Medium confidence
In forceMedium confidence
US 7,985,581Multiple RNA Polymerase III Promoter Expression Constructs
In force
 · High confidence
In forceHigh confidence
US 7,579,451Oligonucleotides Comprising a Modified or Non-Natural Nucleobase
In force
 · High confidence
In forceHigh confidence
US 7,605,251Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
In force
 · High confidence
In forceHigh confidence
US 8,809,292Compositions And Methods For Inhibiting Expression Of The PCSK9 Gene
In force
 · High confidence
In forceHigh confidence
US 9,260,718Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
In force
 · High confidence
In forceHigh confidence
US 9,822,365Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
In force
 · Medium confidence
In forceMedium confidence
US 10,501,742Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
In force
 · Low confidence
In forceLow confidence
US 7,846,908Rnai Modulation of Tgf-Beta and Therapeutic Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 8,124,752Compositions and Methods for Inhibiting Expression of the Myc Gene
In force
 · High confidence
In forceHigh confidence
10 of 308 patents shown.
Pro members see all 308.
Pro members: see all 308 patents
Also on record, not counted in the 308: 51 patents in force now held by others · 144 patents ended · 190 applications pending · 336 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited